Action Plan to Help Patients With Lung Disease Cope With Wildfire Smoke Aug. 19, 2024 — A multidisciplinary team has developed an action plan to help patients with respiratory diseases mitigate ...
Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.